E.E. Geduld’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

E.E. Geduld’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-4,000	Closed	-$97K	–	289
2014 Q3	$97K	Sell	4,000 -1,000	-20%	-$26K	0.07%	182
2014 Q2	$141K	Sell	5,000 -5,000	-50%	-$150K	0.09%	210
2014 Q1	$340K	Buy	10,000 +5,000	+100%	+$171K	0.18%	136
2013 Q4	$96K	Hold	5,000	–	–	0.05%	246
2013 Q3	$81K	Hold	5,000	–	–	0.05%	226
2013 Q2	$53K	Buy	+5,000	New	+$58.6K	0.04%	222

Other funds holding CTIC

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

E.E. Geduld's CTIC Position: Q4 2014 in Review

E.E. Geduld sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2014, closing a stake of 4,000 shares — an estimated $97K sold.

E.E. Geduld first reported a position in CTIC in Q2 2013 and held it in 6 quarters. The position peaked at $340K in Q1 2014. 90 funds tracked by Wall St. Rank hold CTIC as of Q4 2014.

E.E. Geduld reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q4 2014 after selling out during the quarter.
E.E. Geduld sold 4,000 CTI BioPharma Corp. (DE) Common Stock shares in Q4 2014, an estimated $97K.
E.E. Geduld first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 6 quarters.
E.E. Geduld's CTI BioPharma Corp. (DE) Common Stock position peaked at $340K in Q1 2014.
90 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2014.

Based on E.E. Geduld's 13F filing for Q4 2014, filed 30 Jan 2015.